MedTrace Logo

Evaluation of FUSION™ Vascular Graft for Above Knee Targets

NCT01601496 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2020-10-14

Study results available
· View outcomes & findings →

Summary

The purpose of the post-market study was to evaluate the safety and performance of the FUSION Vascular Graft.

Conditions

  • Peripheral Arterial Occlusive Disease (PAOD)

Interventions

DEVICE

FUSION Vascular Graft

All subjects who received the FUSION Vascular Graft at the baseline implant procedure.

Sponsors & Collaborators

  • Maquet Cardiovascular

    lead INDUSTRY

Principal Investigators

  • Prof. Eckstein · Klinikum rechts der Isar

  • Afshin Assadian, MD · Wilhelminenspital Vienna

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-26
Primary Completion
2013-07-24
Completion
2013-07-24
FDA Device
Yes

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01601496 on ClinicalTrials.gov